IFNG and prostate carcinoma: Among these, miR-221 was recently reported and externally validated as an independent predictor of cancer-related death of high-risk prostate cancer patients, by partially regulating JAK/STAT signaling pathway and sensitizing prostate cancer cells to interferon-gamma treatment [17•].